Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine

被引：0
|
作者：
Huaiyu Yang
Lara Sinicropi-Yao
Sarah Chuzi
Soo Jeong Youn
Alisabet Clain
Lee Baer
Ying Chen
Patrick J McGrath
Maurizio Fava
George I Papakostas
机构：
[1] Harvard Medical School,Depression Clinical and Research Program, Massachusetts General Hospital
[2] Columbia University,Depression Evaluation Service Center, New York State Psychiatric Institute
来源：
Annals of General Psychiatry | / 9卷
关键词：
Major Depressive Disorder; Fluoxetine; Major Depressive Disorder; Hamilton Depression Rate Scale; Residual Symptom;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine
    Yang, Huaiyu
    Sinicropi-Yao, Lara
    Chuzi, Sarah
    Youn, Soo Jeong
    Clain, Alisabet
    Baer, Lee
    Chen, Ying
    McGrath, Patrick J.
    Fava, Maurizio
    Papakostas, George I.
    ANNALS OF GENERAL PSYCHIATRY, 2010, 9
  • [2] Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine
    Huaiyu Yang
    Sarah Chuzi
    Lara Sinicropi-Yao
    Dan Johnson
    Ying Chen
    Alisabet Clain
    Lee Baer
    Patrick J. McGrath
    Jonathan W. Stewart
    Maurizio Fava
    George I. Papakostas
    European Archives of Psychiatry and Clinical Neuroscience, 2010, 260 : 145 - 150
  • [3] Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine
    Yang, Huaiyu
    Chuzi, Sarah
    Sinicropi-Yao, Lara
    Johnson, Dan
    Chen, Ying
    Clain, Alisabet
    Baer, Lee
    McGrath, Patrick J.
    Stewart, Jonathan W.
    Fava, Maurizio
    Papakostas, George I.
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2010, 260 (02) : 145 - 150
  • [4] Selective serotonin reuptake inhibitor treatment of major depressive disorder in children and adolescents
    Jeffrey H. Newcorn
    Current Psychiatry Reports, 2004, 6 (2) : 85 - 87
  • [5] Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder
    Perlis, RH
    Nierenberg, AA
    Alpert, JE
    Pava, J
    Matthews, JD
    Buchin, J
    Sickinger, AH
    Fava, M
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (05) : 474 - 480
  • [6] The role of selective serotonin reuptake inhibitors in preventing relapse of major depressive disorder
    Clevenger, Steven S.
    Malhotra, Devvrat
    Dang, Jonathan
    Vanle, Brigitte
    IsHak, Waguih William
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2018, 8 (01) : 49 - 58
  • [7] Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression
    McGrath, PJ
    Stewart, JW
    Petkova, E
    Quitkin, FM
    Amsterdam, JD
    Fawcett, J
    Reimherr, FW
    Rosenbaum, JF
    Beasley, CM
    JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (07) : 518 - 524
  • [8] Adjunctive tianeptine for partial or nonresponders to selective serotonin reuptake inhibitor treatment in major depressive disorder
    Bahk, W. M.
    Jae, Y. M.
    Jon, D. I.
    Min, K. J.
    Paik, K. C.
    Yoon, B. H.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2011, 15 : 16 - 16
  • [9] Effects of selective serotonin reuptake inhibitor treatment on plasma oxytocin and cortisol in major depressive disorder
    Keating, Charlotte
    Dawood, Tye
    Barton, David A.
    Lambert, Gavin W.
    Tilbrook, Alan J.
    BMC PSYCHIATRY, 2013, 13
  • [10] Adjunctive tianeptine for partial or nonresponders to selective serotonin reuptake inhibitor treatment in major depressive disorder
    Bahk, W. M.
    Woo, Y. S.
    Jeong, J. H.
    Kim, W.
    Sung, H. M.
    Koo, B. H.
    Lee, S. H.
    Jon, D. I.
    Min, K. J.
    Yoon, B. H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S389 - S390
12345